---
title: Reduce movement slowness and fatigue
nct_id: NCT06883266
phase: NA
status: RECRUITING
sponsor: Sanford Health
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT06883266"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06883266"
last_fetched: "2026-05-10T14:02:36.716Z"
source: "Parkinson's Pathways (curated)"
---
# Reduce movement slowness and fatigue

**Goal (in five words):** Reduce movement slowness and fatigue

**Official Title:** Transcranial Direct Current Stimulation (tDCS) to Improve Motor Function and Motor Fatigue in Parkinson's Patients

**Trial ID:** [NCT06883266](https://clinicaltrials.gov/study/NCT06883266)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** Sanford Health
- **Target Enrollment:** 64 participants
- **Start Date:** 2024-11-11
- **Completion Date:** 2026-11-11
- **Conditions:** Parkinsons Disease (PD)
- **Interventions:** transcranial direct current stimulation (tDCS), Sham (No Treatment)
- **Intervention Types:** DEVICE

## Summary For Families

The goal is to improve motor function and reduce motor fatigue in people with Parkinson's, targeting the slowness and tiring that make daily activities harder. It uses transcranial direct current stimulation, a gentle, noninvasive electrical current applied to the scalp to boost excitability in motor brain areas and help recalibrate the circuits that control movement; sessions are compared to sham (no treatment), and the approach is intended to be used alongside your usual Parkinson's medications rather than replace them. The trial is looking for adults with a clinical PD diagnosis who have at least two of the core motor signs and can consent, and it excludes people with dementia (MOCA < 21), deep brain stimulation, psychosis, multiple sclerosis, stroke, COPD, or congestive heart failure.

## Eligibility

- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* Clinical diagnosis of PD with at least two of the four diagnostic criteria for PD (tremor, rigidity, bradykinesia, and postural instability)
* Must be able to consent

Exclusion Criteria:

* Patients with dementia (MOCA \< 21)
* PD treatment using deep brain stimulation (DBS)
* Diagnosis of psychosis
* Diagnosis of multiple sclerosis
* Diagnosis of stroke
* Diagnosis of chronic obstructive pulmonary disease (COPD)
* Diagnosis of congestive heart failure (CHF)
```

## Locations (1)

- Sanford Brain and Spine Center, Fargo, North Dakota, United States _(46.8772, -96.7898)_
  - Jessica Keller, B.S. — (CONTACT) — 701-417-5781 — jessica.keller@sanfordhealth.org
  - Jau-Shin Lou, MD — (PRINCIPAL_INVESTIGATOR)

## Central Contacts

- Jessica Keller, B.S. — (CONTACT) — 701-417-5781 — jessica.keller@sanfordhealth.org

---

*Canonical: https://parkinsonspathways.com/trial/NCT06883266*  
*HTML version: https://parkinsonspathways.com/trial/NCT06883266*  
*Source data: https://clinicaltrials.gov/study/NCT06883266*